Clinical Trial Search

Primary: Percent Change From Baseline in Low-Density Lipoprotein Cholesterol (LDL-C) at Week 12 — -3.71; 4.54; -14.26; -40.98 percent change — p=<0.001

Primary: Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform — 12; 7; 8; 23 participants

Primary: CGM Relative Differences to Laboratory Reference — 13 Percentage of difference — p=0.0001

Primary: Feasibility to Mobilize and Infuse Autologous Lymphocytes (ALI) After Immunomodulatory Therapy and After Stem Cell Transplant Engraftment — 17; 16; 1 participants

Primary: Ocular Surface Disease Index© (OSDI) Score Using a 5-Point Scale — 6.99; 6.63 Scores on a Scale

Primary: Percent Change From Baseline in Low-Density Lipoprotein Cholesterol (LDL-C) at Week 12 — -2.71; 0.05; -55.56; -71.32 percent change — p=<0.001

Primary: Mean Area Under the Curve for Rise in Breakfast Post-prandial. — 61; 583 min x (mmol/l)

Primary: Percent of Participants Who Responded to Therapy — 5.6; 11.8; 52.6; 47.1 percentage of participants — p=0.5282

Primary: Geometric Mean Ratio of Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Observed Sampling Time (AUC[0-last]) of Probe Parent Drugs — 2.56…

Primary: Percentage of Participants Who Achieved Disease Activity Score Based on 28-joint Count (DAS-28) and Erythrocyte Sedimentation Rate (DAS28-ESR) Remission at 6 Months…

Primary: The Rate of Complete Effectiveness of Initial GIS Management Strategy — 55.9; 67.2 percentage of participants — p=0.2554

Primary: Mechanical Lens Fit Acceptance — 345; 337 Eyes

Primary: Percentage of Participants Who Tested Positive for EGFR Mutations — 8.1 percentage of participants

Primary: Postoperative Pain — .8; 2.0; 2.2; 3.3 units on a scale

Primary: Papilla or Duct-enterostomy Was Reached — 10 ERCPs